Tu sei qui: Home > Cannabinoids (precedente) > THC can improve symptoms of schizophrenia
Cannabinoids 2009;4(4):1-3 (November 21, 2009)
Article of the Month
THC can improve symptoms of schizophrenia
Franjo Grotenhermen
nova-Institut, Chemiepark Knaps
Scientists at the Rockland Psychiatric Center in Orangeburg, New York, reported of an improve-ment of schizophrenia symptoms in 4 patients who received oral dronabinol (THC) (Schwarcz et al. J Clin Psychopharmacol 2009;29(3):255-8). Only patients with a previous history of self-reported benefits from cannabis use were selected. In addition, they presented with a severe, re-fractory condition that made the possible benefits outweigh the risks. Dronabinol administration was initiated at 2.5 mg twice a day and subsequently raised to 5 mg twice a day in the second week and 10 mg twice a day in the third week. One of the patients needed 8 weeks to reach sig-nificant improvement, while the others responded to the therapy within a shorter period of time. Researchers noted that "this improvement seems to have been a reduction of core psychotic symp-toms in 3 of the 4 responders and not just non-specific calming."
Keywords
cannabis, THC, dronabinol, schizophrenia, psychosis, case report
Eventi online 2020
Tutte le informazioni sugli eventi online dell'IACM, compresi i video gratuiti dei webinar con sottotitoli in italiano, si possono trovare qui.
Conferenza IACM 2022
La 12a Conferenza IACM sui cannabinoidi in medicina si terrà il 20 e 21 ottobre 2022 insieme alla SSCM svizzera a Basilea/Svizzera.
Members only
Regular members can sign up for the new member area of the IACM to access exclusive content.
You need to become a regular member of the IACM to access the new member area.
IACM on Twitter
Follow us on twitter @IACM_Bulletin where you can send us inquiries and receive updates on research studies and news articles.